Home Clinical Topics Ophthalmology

Ophthalmology

First FDA approved treatment for thyroid eye disease

The U.S. Food and Drug Administration (FDA) recently approved Horizon Therapeutics Ireland DAC’s teprotumumab-trbw (Tepezza) as the first FDA-approved treatment for adults with thyroid eye disease (TED). TED is a rare disorder which causes the...

Poor diet increases risk for late-stage age-related macular degeneration

A new study from the British Journal of Ophthalmology has revealed a link between poor diet and the increased risk of age-related macular degeneration (AMD). AMD is irreversible and affects the central vision, impacting...